Aptose Biosciences Inc. (APTOF) › Shareholders' EquityAptose Biosciences Inc. (APTOF) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: $7.33M2017: $10.20M2018: $14.08M2019: $93.93M2020: $118.92M2021: $74.24M2022: $37.74M2023: -$2.90M2024: -$4.54M2025: -$27.17M-$27.17M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$27.17M-498.0%2024-$4.54M-56.6%2023-$2.90M-107.7%2022$37.74M-49.2%2021$74.24M-37.6%2020$118.92M+26.6%2019$93.93M+567.0%2018$14.08M+38.0%2017$10.20M+39.2%2016$7.33M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share